Two-year feasibility study results encouraging with Medtronic Harmony(TM) transcatheter
Medtronic announced two-year outcomes for the Harmony Transcatheter Pulmonary Valve from its early feasibility study. Designed to offer a treatment alternative for patients with CHD, the Harmony TPV is being studied in CHD patients born with RVOT anomalies who undergo surgical repair early in life. April 26, 2018